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Objective: To estimate the age and sex-specific prevalence of HIV infection in the
population of Addis Ababa, Ethiopia. 
Design: Two-stage cluster sampling of the population aged 0–49 years of Addis
Ababa, using kebeles (urban dwelling associations) as clusters. 
Methods: The sera used for this study were collected in an earlier study (1994) on
the rate of acquisition of antibodies against measles, rubella, and hepatitis B. After
separate approvals were obtained from the institutional ethics committees, sera were
tested by enzyme-linked immunosorbent assay confirmed by Western blot. Age- and
sex-specific HIV prevalence rates were estimated. The prevalence of HIV in men
and women over 15 years of age was compared by calculating age-standardized
HIV prevalence, using the age distribution of the census population as the standard.
A time-dependent catalytic model was used to obtain crude estimates of HIV
incidence from age-prevalence data. 
Results: A total of 3853 sera were available for analysis. The prevalence of HIV in
adults was 6.0% [95% confidence interval (CI), 4.5–7.4%] for men and 6.9% (95% CI,
5.3–8.5%) for women, with peak prevalence in the 25–29 year age group of 16.3 and
11.8%, respectively. After standardization for age using the direct method, the HIV
prevalence ratio comparing adult men with women was 0.97 : 1 (95% CI, 
0.70 : 1 – 1.35 : 1). Three children aged less than 5 years were HIV-positive. The
prevalence of HIV among adults ranged from 0–21.3% in different clusters, indicating
the heterogeneity of the spread of HIV in the city. HIV prevalence estimates among
the antenatal clinic patients of Addis Ababa in 1996 far exceeded the estimates
obtained during the community survey, particularly in the youngest age group (15–24
years). Estimates of HIV incidence (per susceptible person per annum) for the age
group 16–22 years ranged from 1.3–2.25% for men and from 2.1–2.4% for women. 
Conclusion: By 1994, a substantial proportion of the adult population of Addis
Ababa was infected with HIV. Promotion of behavioural changes and the control of
sexually transmitted diseases should be strongly supported to limit the spread of the
HIV epidemic in Ethiopia.
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Introduction
Ethiopia, as with most of Africa, has been experiencing
a severe HIV/AIDS epidemic during the past 10 years.
The first Ethiopian sera found positive for HIV-1 anti-
bodies date from 1984 [1]. Retrospective analysis of
samples collected in the early 1980s failed to reveal
HIV antibodies [2]. The first AIDS cases were diag-
nosed in the hospitals of Addis Ababa, the capital city,
in 1986 [3]. High rates of HIV prevalence were soon
detected along the main trading roads of the country,
with HIV seroprevalence rates of 17% among 6234
commercial sex workers and 13% among 468 truck dri-
vers working along these roads in 1988 [4,5]. In 1994,
data from 11 urban blood bank centres showed that the
prevalence of HIV varied from 5–20%, being 6.6% in
Addis Ababa (National Blood Transfusion Service,
Ethiopian Red Cross Society, personal communication,
1994). Among antenatal clinic patients in Addis Ababa,
11–13% were HIV-positive in 1991 [6]. Estimates of
HIV prevalence among pregnant women or blood
donors are restricted to certain age-groups and loca-
tions, and may be biased by access to health care or the
motivation for giving blood. To obtain a more com-
prehensive assessment of the HIV epidemic in Addis
Ababa we tested sera, obtained from the age-group
0–49 years in a community-based survey in 1994, for
HIV antibodies.
Patients and methods
The sera used for this study were collected (by T.M.,
A.D., F.E., A.A., F.T.C., H.Y., D.J.N.) in an earlier
study on the rate of acquisition of antibodies against
measles, rubella and hepatitis B. Addis Ababa has an
estimated population of 2 300 000 [7]. The city is orga-
nized into 305 kebeles (urban dwelling associations).
Twenty kebeles from the inner city and 20 kebeles
from the outer city of Addis Ababa were selected by
cluster sampling with probability proportional to esti-
mated size (based on the projections from the 1984
census). From each kebele (size ranging from 523 to
2868 households), 30 households were randomly
selected and visited over the period May–October
1994. In each household, informed consent was
obtained from the head of the household for the inter-
view and collection of blood from household members.
A questionnaire including socio-demographic variables
was administered and blood samples were collected by
venepuncture, using sterile vacutainers, from all indi-
viduals under the age of 50 years, except for the age
group 5–15 years, from which only one in every two
was selected by tossing a coin. Samples were trans-
ported in cold boxes to the Ethiopian Health and
Nutrition Research Institute (EHNRI) laboratory and
aliquots stored in vials at –20°C.
In late 1994, the Ethiopian–Netherlands AIDS
Research Project (ENARP) was established at the
Ethiopian Health and Nutrition Research Institute
(EHNRI) in Addis Ababa. Obtaining an updated figure
on the spread of the HIV epidemic in Addis Ababa was
considered important, and the availability for HIV test-
ing of the above-described samples was discussed with
the investigators of the original study. As consent for
HIV testing had not been obtained from heads of
households during the original study, separate ethical
approvals for HIV testing were requested from the
EHNRI Ethical Committee and the Central Oxford
Research Ethics Committee. The recommendations of
the two committees did not require us to obtain
approval from the head of households for HIV screen-
ing, but required the results to be entered in a data set
from which the names were deleted and the house num-
bers altered, rendering it impossible to link HIV test
results with individuals (i.e., anonymous unlinked test-
ing). In order to preserve the anonymity for clusters with
high HIV prevalence, it was also decided that the study
results should not be published in the form of a map of
the city. Sera were tested for HIV-1 antibodies using
enzyme-linked immunosorbent assay (ELISA)
(Vironistika; Organon, Boxtel, The Netherlands). All
positive samples were further analysed by the
Wellcozyme recombinant ELISA (Wellcome
Diagnostics, Dartford, Kent, UK). Samples with results
positive by both assays were considered positive. Samples
with discordant results were tested by Western blot
(Diagnostic Biotechnology, Singapore) and those with
positive results were considered as confirmed positive.
The age and sex distribution of the population sur-
veyed was compared to that of the census carried out in
Addis Ababa as part of the national census of Ethiopia
in October 1994. Age- and sex-specific HIV preva-
lence rates and their 95% confidence intervals (CI)
were estimated, applying to each observation weights
that were inversely proportional to the probability of
being sampled, and using formulae appropriate for
stratified cluster surveys with unequal response rates per
cluster [8]. Calculations were done using the survey
analysis features of Stata Statistical Software (Stata
Corporation, College Station, Texas, USA). The
prevalence of HIV in men and women aged at least 15
years was compared by calculating the age-standardized
HIV prevalence, using the age distribution of the 1994
census population as the standard. A standardized
prevalence ratio was calculated as the ratio of the stan-
dardized prevalence of HIV in adult men (Pm) and
adult women (Pf ). The standard error (SE) of this ratio
was calculated from:
SE (log(Pm/Pf )) = [var(Pm)/Pm
2 + var(Pf)/Pf
2]
0.5
where var(Pm) = Swj
2dj(nj – dj)/nj
3 and for each age
stratum j, wj is the proportion of the standard popula-HIV prevalence in Addis Ababa Fontanet et al. 317
tion in that stratum, nj the number of men (weighted),
and dj the number of HIV-infected men (weighted).
The value of var(Pf ) was calculated in the same man-
ner. These formulae are derived from [9] with appro-
priate modifications to binomial variances [10].
The results of the home-based survey were compared
with results obtained during the unlinked anonymous
testing of 1145 pregnant women in four antenatal care
clinics of Addis Ababa in 1996 (sentinel surveillance
system). First, the catchment area of each antenatal care
clinic was determined by recording from the clinic reg-
istries the addresses of all women attending for antena-
tal care during the sentinel surveillance data collection
period. Since there were too few antenatal clinic
patients from individual kebeles included in the com-
munity survey for meaningful comparisons to be made,
we based the catchment areas on a larger administrative
unit called woreda. The catchment area of each clinic
was defined by starting with those woredas with the
highest number of antenatal clinic patients, and adding
woredas with progressively fewer antenatal patients
until at least 80% of all women registered in that clinic
were included. Then, we compared the HIV preva-
lence estimates obtained in 1996 for each catchment
area with the estimates among women aged 15–44
years living in the corresponding woredas in the 1994
community survey. Finally, we compared the age-
group-specific HIV prevalence rates (15–24, 25–34 and
35–44 years) between pregnant women in 1996 and
women of the same age surveyed at home in 1994.
Estimates of HIV incidence for men and women aged
16–22 years were obtained from age-prevalence data
using a time-dependent catalytic infection model
[11–13]. We made the assumption that the proportion
of individuals who were antibody-positive at a particu-
lar age was equivalent to the cumulative incidence of
HIV infection throughout the time period during
which those individuals were exposed. Thus it was
assumed that there was no loss of HIV seropositivity
after infection, migration in and out of the city was not
associated with HIV status, and HIV-associated mortal-
ity was negligible before the age of 23 years. HIV
exposure was assumed to begin at age 16 for both
sexes. The small fraction of seropositive women in the
age range 14–16 years (< 1.5%) was treated as negligi-
ble; thus all individuals were assumed susceptible at age
16 years. Observed seroprevalence by age, at the time
of the survey in 1994, was modelled as the outcome of
a process of infection, the ‘force of infection’ [14] act-
ing on a decreasing fraction susceptible, beginning at
age 16 years. The force of infection, which is the rate
of primary infection per susceptible individual, was
assumed to act uniformly over the specified age range
of 16–22 years at any one point in time, but we exam-
ined the possibility that it had increased over the last
decade as the epidemic had developed in Addis Ababa.
The catalytic infection model was fitted by maximum
likelihood to data for men and women separately, using
constant, linear or exponential functions for the force
of infection over time. Assessment of the significance of
difference between the fit to the data of the one-para-
meter model (constant) and each of the two-parameter
models (linear and exponential) and calculation of 95%
confidence intervals around the force of infection esti-
mates for 1994 were based on the log-likelihood
approximation to a c
2 distribution [12].
Results
A total of 7750 individuals aged 0–49 years were sur-
veyed from the households selected for the study (4083
in the inner and 3667 in the outer city). The age struc-
ture of the sample population is shown in Table 1, and
compared with the age structure of the 1994 census.
The modal age group is 15–19 years, and there is an
excess of women over men for all age classes except the
youngest (0–4 years) and the oldest (45–49 years). This
structure is similar in the inner and outer city (data not
shown). Compared with the 1994 census population,
the study population over-represented the younger age
groups (younger than 25 years of age) and under-repre-
sented the older ages for men, but it matched the age
distribution of the 1994 census population for women.
Blood samples were obtained from 4675 individuals
whose age and sex distribution reflected that of the
population surveyed. Compliance in providing a blood
sample was 61% over the age group 0–49 years, with a
low of 35% among men aged 40–44 years and a high of
75% among women aged 35–39 years. In the 5–15
years age group, samples were obtained from over 50%
of the individuals surveyed, suggesting that the process
of selecting individuals by the toss of a coin was not
strictly enforced. As samples were primarily used for
testing for antibodies against measles, rubella and
hepatitis B, the remaining serum of only 3853 individ-
uals was available for HIV antibodies testing. The age
and sex distribution of the population from which
blood samples were used for analysis reflected that of
the population surveyed (Table 1).
Age- and sex-specific HIV prevalence rates are shown
in Table 2 and Fig. 1. The peak HIV prevalence was in
the age group 25–29 years, being 16.3% (95% CI,
8.9–23.7%) for men and 11.8% (95% CI, 8.4–15.2%)
for women. When only adults (over 15 years of age)
were considered, the prevalence of HIV was 6.0% (95%
CI, 4.5–7.4%) and 6.9% (95% CI, 5.3–8.5%) for men
and women, respectively. The age-standardized male-
to-female HIV prevalence ratio was 0.97 (95% CI,
0.70–1.35). HIV prevalence among adults of the inner
city was higher than among adults of the outer city, but
this difference was marginally significant (inner city,AIDS 1998, Vol 12 No 3 318
8.2%; 95% CI, 6.2–10.2% versus outer city 5.3%; 95%
CI, 4.1–6.6%). There was a large variation of HIV
prevalence among adults between the clusters, from 0%
(95% CI, 0–7%) to 21.3% (95% CI, 11.8–30.8%).
There were large differences between the HIV preva-
lence estimates obtained at the antenatal care clinics in
1996 and their corresponding catchment areas in the
1994 survey (Table 3). When data from the four areas
were pooled together, HIV prevalence among pregnant
women was 204 out of 1145 (17.8%), compared with
35 out of 671 (5.2%) among women surveyed at home
(P < 0.05), and this difference was little changed after
standardization for age. Interestingly, the difference
between age group-specific HIV prevalence estimates
was much larger in the age group 15–24 years (16.4%)
than in the age group 25–34 years (8.9%). In the age
group 35–44 years, there was a non-significant differ-
ence of only 1.7%.
Three children less than 5 years of age, all girls, were
HIV-positive. In one case, both parents were tested dur-
ing the survey and found to be HIV-negative. In the
two other cases, the parents were not tested during the
survey. There was no HIV infection in the age group
6–13 years. The first HIV-positive samples among young
adolescents were observed at age 14 years for women
and 15 years for men. HIV prevalence in the age-group
15–19 was higher among women (3.5%; 95% CI,
1.8–5.1%) than in men (1.8%; 95% CI, 0.1–3.5%), but
the difference was not statistically significant.
Figures 2a and 2b show the predicted age-prevalence
over the ages 16–22 years in 1994 using a catalytic infec-
tion model, assuming constant, linear or exponential
forms for the force of infection over time, for men and
women, respectively. Corresponding estimates of the
time-dependent force of infection (i.e., per susceptible
rate of infection per year) over the period 1986 to 1994
Table 1. Comparison of the age distribution of the 1994 census population with that of the population surveyed, and that of the population
from which blood samples were used for serological analysis.
1994 census population Population surveyed Blood samples analysed
Age (years) n (%) n (%) n (%)
Men
0–4 85 808 (8.9) 314 (8.9) 121 (8.3)
5–9 108 489 (11.3) 455 (12.8) 226 (15.4)
10–14 133 471 (13.9) 587 (16.6) 298 (20.4)
15–19 147 218 (15.3) 645 (18.2) 283 (19.3)
20–24 129 919 (13.5) 500 (14.1) 185 (12.6)
25–29 100 445 (10.4) 304 (8.6) 94 (6.4)
30–34 70 030 (7.3) 196 (5.5) 84 (5.7)
35–39 63 485 (6.6) 191 (5.4) 70 (4.8)
40–44 50 478 (5.2) 170 (4.8) 49 (3.3)
45–49 74 029 (7.7) 178 (5.0) 53 (3.6)
Total 963 372 (100) 3540 (100) 1463 (100)
Women
0–4 84 859 (8.5) 308 (7.3) 121 (5.1)
5–9 111 190 (11.1) 478 (11.4) 250 (10.5)
10–14 145 996 (14.6) 664 (15 8) 371 (15.5)
15–19 186 305 (18.6) 858 (20.4) 510 (21.3)
20–24 146 393 (14.6) 597 (14.2) 326 (13.6)
25–29 110 036 (11.0) 388 (9.2) 238 (10.0)
30–34 69 564 (7.0) 268 (6.4) 145 (6.1)
35–39 72 648 (7.3) 323 (7.7) 218 (9.1)
40–44 41 109 (4.1) 174 (4.1) 111 (4.6)
45–49 31 884 (3.2) 152 (3.6) 100 (4.2)
Total 999 984 (100) 4210 (100) 2390 (100)
Total 1 963 356 7750 3853
Table 2. HIV-1 prevalence by age, sex and residence.
HIV-positive/total (%)
Age (years) Inner city Outer city Total*
Men
0–4 0/62 (0) 0/59 (0) 0/121 (0)
5–9 0/118 (0) 0/108 (0) 0/226 (0)
10–14 0/165 (0) 0/133 (0) 0/298 (0)
15–19 5/157 (3.2) 1/126 (0.8) 6/283 (1.8)
20–24 5/121 (4.1) 3/64 (4.7) 8/185 (4.5)
25–29 12/64 (18.9) 4/30 (13.3) 16/94 (16.3)
30–34 3/53 (5.7) 5/31 (16.1) 8/84 (11.1)
35–39 6/38 (15.8) 3/32 (9.4) 9/70 (11.9)
40–44 1/29 (3.4) 0/20 (0) 1/49 (1.6)
45–49 3/34 (8.8) 0/19 (0) 3/53 (4.7)
Total 35/841 (4.2) 16/622 (2.6) 51/1463 (3.3)
Women
0–4 1/71 (1.4) 1/50 (2.0) 2/121 (1.6)
5–9 0/131 (0) 1/119 (0.8) 1/250 (0.8)
10–14 1/229 (0.4) 0/142 (0) 1/371 (0.2)
15–19 14/282 (5.0) 6/228 (2.6) 20/510 (3.5)
20–24 19/196 (9.7) 10/130 (7.7) 29/326 (9.1)
25–29 21/146 (14.4) 9/92 (9.8) 30/238 (11.8)
30–34 5/89 (5.6) 4/56 (7.1) 9/145(7.5)
35–39 15/137 (10.9) 1/81 (1.2) 16/218 (6.1)
40–44 6/60 (10.0) 3/51 (5.9) 9/111 (7.4)
45–49 1/55 (1.8) 3/45 (6.7) 4/100 (6.1)
Total 83/1396 (5.9) 38/994 (3.8) 121/2390 (4.9)
Percentage weighted to take account of the stratified cluster 
sampling scheme, so they are not identical to the unweighed 
percentage that can be calculated from this column.HIV prevalence in Addis Ababa Fontanet et al. 319
for men and women are shown in Fig. 3a and 3b,
respectively. The models with linear or exponential
functions provided only marginal improvement in fit to
the observed data compared with a constant force of
infection (Table 4). The improvement in fit was not
significant, but for men, the variation in seroprevalence
by age is best explained by the exponential model 
(Fig. 2a) when standardized residuals are viewed (data
not shown) [12]. The number of samples available for
each age was between 43 and 73 for men, and between
70 and 130 for women (except for age 21 years where
it was only 41 and 38 for men and women, 
respectively, probably due to rounding errors during
collection of age data). Estimates of annual rates of HIV
incidence per susceptible person aged 16–22 years for
the year 1994 are shown in Table 4 for each 
time-dependent form of the force of infection. Annual
estimates for men range from 1.26% (constant) to
2.25% (exponential), and for women from 2.13% 
(constant) to 2.42% (exponential).
Fig. 1.  Age- and sex-specific HIV prevalence rates in Addis Ababa population, 1994. Men, dark grey bars; women, light grey
bars.
Table 3. Comparison of HIV prevalence in women aged 15–44 years in Addis Ababa, Ethiopia between the 1994 home-based survey and the
1996 antenatal care clinic-based survey.
HIV-positive/total (%)
Home-based survey 1994 Antenatal care clinics 1996 P value
By geographical area, all ages combined
Area 1 10/169 (5.9) 66/247 (26.7) < 0.001
Area 2 16/274 (5.8) 64/298 (21.5) < 0.001
Area 3 6/125 (4.8) 47/300 (15.7) 0.002
Area 4 3/103 (2.9) 27/300 (9.0) 0.04
By age group, all four areas combined
15–24 16/373 (4.3) 126/608 (20.7) < 0.001
25–34 12/157 (7.7) 74/447 (16.6) 0.006
35–44 7/141 (5.0) 6/90 (6.7) > 0.05
Total 35/671 (5.2) 204/1,145 (17.8) < 0.001
Total, standardized for age* 5.5% 16.4%
*Using the 1994 census female age distribution as standard.AIDS 1998, Vol 12 No 3 320
Discussion
This study demonstrates that by 1994, a substantial pro-
portion of the adult population in Addis Ababa was
HIV-positive. The peak of HIV prevalence in the age
group 25–29 years may indicate that the epidemic is
still recent, as there is increasing evidence for a peak
concentration of HIV infection in younger age groups
(younger than 25 years of age) in mature epidemics in
Africa [15,16]. Women tended to become infected
slightly younger than men, probably because of earlier
initiation of sexual activity and exposure to older sexual
partners that were already HIV-infected. The age-
standardized male-to-female prevalence ratio was
almost unity, suggesting that the predominant route of
transmission is heterosexual, in a country where inject-
ing drug use is very limited. This finding is corrobo-
rated by interviews with Ethiopian AIDS patients,
where a history of multiple sexual partners was the
main risk factor for HIV infection [17]. Also, among
AIDS cases, the male-to-female prevalence ratio gradu-
ally shifted from 3.7 in 1988 to 1.5 in 1994 [17] as
might be expected if the epidemic started with a core
group of women with multiple partners (commercial
sex workers, for example) and subsequently spread to
the general population.
The similarity of the age and sex distribution of the
individuals included in the survey, to that of the 1994
census of Addis Ababa, provides good evidence that the
population surveyed in this study was representative of
the general population of the city. The difference
between the proportion of samples obtained from adult
men and women (47% and 68%, respectively) suggests
that absence for work or travel may have played a sub-
stantial role in the unavailability of samples in adults. As
men who travel frequently are more likely to be at an
increased risk of HIV infection, our estimate of the
HIV prevalence in adult men may be an underestimate.
Very few children under 5 years of age were HIV-
positive. One 5-year-old girl was HIV-infected
whereas both her parents were HIV-negative. It is pos-
sible that HIV was transmitted parentally, although we
have no data on the administration of transfusions or
injections. After the ages 6–13 years, where no HIV-
positive sera were found, the first HIV-positive sera
were identified at age 14 years for women and 15 years
for men. These cases are more likely to be related to
Table 4. Predicted HIV incidence in 16–22 year-olds in 1994,
Addis Ababa.
Predicted  95%
incidence I0 confidence
Model (%/year) interval –ln L
Men
Constant 1.26 0.46–2.70 21.09
Linear* 1.70 1.27–3.11 21.00
Exponential 2.25 0.81–4.80 20.98
Women
Constant 2.13 1.22–3.41 53.07
Linear* 2.42 1.51–3.69 53.05
Exponential 2.44 1.40–3.90 53.05
I0, Force of infection (per susceptible incidence) at time of survey
(1994). –ln L, Minimized log-likelihood which gives the best 
(i.e. maximum-likelihood) fit of the model to the data.
*Linear, the force of infection was constrained to be positive
throughout the period 1986–1994 (i.e., over an 8-year period in
which individuals in the age range 16–22 years could have been
exposed to infection).
Fig. 2. Descriptions of observed HIV age-prevalence for
men (n, graph a) and women (n n, graph b) in the age range
16–22 years predicted using a catalytic infection model in
which the force of infection acting on susceptible people is
assumed constant (––––), linearly increasing (- - - -) or expo-
nentially increasing (–– - –– -), over time. The number of
samples available for each age ranged between 43 and 73
for men, and between 70 and 130 for women (except for
age 21 where it was only 41 and 38 for men and women
respectively, probably due to rounding errors during collec-
tion of age data). HIV prevalence in Addis Ababa Fontanet et al. 321
initiation of sexual activity, underlining the need to
include young people in HIV prevention programmes
since sexual transmission of HIV may start as early as 14
years of age.
The HIV prevalence among adults showed wide varia-
tion between clusters, ranging from zero to 21%. This
large variation in HIV prevalence was also observed in
pregnant women attending four antenatal care clinics of
Addis Ababa in 1996 (Table 3). However, the figures
obtained among pregnant women in 1996 were strik-
ingly higher than those obtained among women during
the community survey in 1994, even after adjustment
for age. There are many factors which may explain
why HIV prevalence estimates in antenatal clinic
patients would differ from those obtained in the female
adult population [18]. What surprised us was the obser-
vation of an opposite trend to the one documented in
Tanzania, where pregnant women gave an underesti-
mate of the HIV prevalence measured in the female
general population [10].  One likely explanation is that
the HIV epidemic is still in its expansion phase in Addis
Ababa, and that HIV incidence rates have been high
during the 2 years separating the two surveys. Another
explanation is that some women with high-risk 
behaviours in the community survey may have been
reluctant to provide blood, fearing HIV testing even
though the survey was not initially designed for this
purpose. This bias would not be present in the preg-
nant women population, as the HIV testing was done
unlinked and anonymously, as recommended by the
World Health Organization for surveillance purposes
[19]. The differences between 1996 clinic-based and
1994 community-based estimates narrowed consider-
ably in the higher age groups. Among women aged
15–24 years, becoming pregnant may reflect sexual
behaviours that are also associated with an increased
risk of HIV infection, thus HIV-infected women
would be over-represented among antenatal clinic
patients. In contrast, in the oldest age group, the
decrease in fertility associated with advanced HIV
infection and/or coincident chronic sexually transmit-
ted or pelvic inflammatory disease, would result in an
under-representation of HIV-infected women among
antenatal clinic patients. Whether the differences in
HIV prevalence observed between the sentinel surveil-
lance sites will persist or be equalized with time may
depend, either on whether sexual behaviours and mix-
ing patterns differ, or whether HIV was introduced at
different times among the sites. As was already observed
in Bujumbura, Burundi, a single sentinel site may not
be sufficient to monitor the spread of the HIV epi-
demic in large cities [20]. Although HIV prevalence
among adult blood donors in 1994 was very similar to
the one observed in the survey, the recent enforcement
of measures to screen out donors with high-risk sexual
behaviour may in the future reduce the measured HIV
prevalence in this group. 
We obtained crude estimates of HIV incidence in
Addis Ababa in 1994 from cross-sectional age–
seroprevalence data based upon a time-dependent 
catalytic infection model. Results of the analysis pro-
vide estimates of HIV incidence (per susceptible person
per year) in the age range 16–22 years in 1994 of
1.3–2.25% for men and 2.1–2.4% for women, depen-
dent upon the assumptions of time-dependence in the
rate of transmission. Ideally, one would like to use the
data to predict the future course of the epidemic, but as
discussed below, there are several limitations on the use
of cross-sectional data for this purpose. We restricted
the analysis to the age range 16–22 years to minimize
bias due to HIV-associated mortality and to overcome
the confounding effects of age- and time-related rates
of transmission. Thus it was assumed that over this age
range, age-related variation in exposure rates due to
variation in factors such as sexual activity were not sig-
nificant. It is not possible to extrapolate the incidence
estimates obtained to other age groups. An indication
that HIV incidence is rapidly increasing in other age
groups is provided by the 1996 antenatal surveillance
data in the city which showed markedly higher preva-
lence than was recorded amongst women of similar age
in the present (1994) survey.
The resolution of age and time components of trans-
mission that contribute to age- prevalence would
require additional independent data on one or other of
the factors on repeated cross-sectional data over time
[12,21,22]. Future analysis might explicitly account for
age-related exposure in assuming that an increasing
fraction is sexually active as age increases. Although it
seems highly probable that HIV incidence in Addis
Ababa has increased over the last decade as the epi-
demic has taken hold, there is no significant indication
of a time-dependent force of infection from the 
seroprevalence data analysis, although there is some
evidence for an exponentially increasing trend for men.
This result is probably explained by the small number
of ages included in the analysis (low degrees of 
freedom) and the heterogeneity in rates of exposure
between these individuals that is independent of age.
Information on the nature of this trend in HIV inci-
dence is of crucial public health importance; as shown
in Fig. 3, because an exponential trend would give
great cause for concern. 
These prevalence and derived incidence data confirm
the rapid expansion of the HIV epidemic in Addis
Ababa and call for the urgent application of effective
prevention programmes. Promotion of behavioural
changes and control of sexually transmitted diseases are
known to be effective against HIV transmission at the
community level [23,24], and should be strongly sup-
ported to limit the spread of the HIV epidemic in
Ethiopia.AIDS 1998, Vol 12 No 3 322
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Fig. 3. Predicted forces of infection (i.e., per susceptible
incidence per year) over time for men (a) and women (b)
corresponding to the use of a catalytic infection model in
which the force of infection acting on susceptible people is
assumed constant (____), linearly increasing (- - - -) or
exponentially increasing (–– - –– -), over time,  (the force of
infection in 1994 corresponds to the I0 values given in
Table 4).